CareFusion Flies Solo: Flu Prep, Alaris Relaunch Aid First Earnings Report
This article was originally published in The Gray Sheet
Executive Summary
CareFusion spun off on its own at a difficult time for a company that depends heavily on hospital capital equipment spending, but with an infusion pump relaunch and a little help from the H1N1 flu, the firm had a relatively successful debut quarter
You may also be interested in...
CareFusion Mulls Relaunch Of Alaris SE After FDA Lifts Injunction
CareFusion said it is evaluating a timeline for re-introducing its Alaris SE infusion pump after FDA recently informed the firm it has lifted an injunction barring sales of the devices in the U.S
CareFusion Mulls Relaunch Of Alaris SE After FDA Lifts Injunction
CareFusion said it is evaluating a timeline for re-introducing its Alaris SE infusion pump after FDA recently informed the firm it has lifted an injunction barring sales of the devices in the U.S
Hospitals Seek More Data To Inform MedTech Purchases, But Will They Buy?
A potential leading indicator for hospital capital equipment purchasing trends suggests an upswing in sales could be in the offing